Literature DB >> 8943410

Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI.

G Senaldi1, S Yin, C L Shaklee, P F Piguet, T W Mak, T R Ulich.   

Abstract

The aim of this study was to examine the role of TNF receptor I (TNF-RI) in the pathogenesis of heat-killed Corynebacterium parvum- and live bacillus Calmette-Guerin (BCG)-induced granulomas. Granuloma formation was analyzed in TNF-RI knockout mice and after treatment with soluble TNF-RI (sTNF-RI). TNF-RI knockout mice injected with C. parvum or BCG developed fewer and smaller granulomas than wild-type control mice. Mice treated with sTNF-RI from days 7 to 13 after injection of C. parvum or BCG developed fewer and smaller granulomas than saline-treated control mice. Established granulomas regressed in rats treated with sTNF-RI from days 10 to 13 after injection of C. parvum. In conclusion, TNF signaling via TNF-RI contributes to the pathogenesis of C. parvum- and BCG-induced granulomas. sTNF-RI inhibits the development of granulomas and can cause the regression of established granulomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943410

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Acne: a review of immunologic and microbiologic factors.

Authors:  C G Burkhart; C N Burkhart; P F Lehmann
Journal:  Postgrad Med J       Date:  1999-06       Impact factor: 2.401

2.  Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen.

Authors:  Christina M Coyle; Louis M Weiss; Luther V Rhodes; Ann Cali; Peter M Takvorian; Daniel F Brown; Govinda S Visvesvara; Lihua Xiao; Jaan Naktin; Eric Young; Marcelo Gareca; Georgia Colasante; Murray Wittner
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

Review 3.  Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.

Authors:  Thomas W Spahn; Hans-Pietro Eugster; Adriano Fontana; Wolfram Domschke; Torsten Kucharzik
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 4.  Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.

Authors:  Raja K Sivamani; Heidi Goodarzi; Miki Shirakawa Garcia; Siba P Raychaudhuri; Lisa N Wehrli; Yoko Ono; Emanual Maverakis
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

5.  Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis.

Authors:  Roanne Keeton; Nasiema Allie; Ivy Dambuza; Brian Abel; Nai-Jen Hsu; Boipelo Sebesho; Philippa Randall; Patricia Burger; Elizabeth Fick; Valerie F J Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 6.  Emerging biologics in inflammatory bowel disease.

Authors:  Heyson Chi-Hey Chan; Siew Chien Ng
Journal:  J Gastroenterol       Date:  2016-11-10       Impact factor: 7.527

7.  Natural killer T cells suppress zymosan A-mediated granuloma formation in the liver by modulating interferon-γ and interleukin-10.

Authors:  Takahiro Kobayashi; Hiroki Kawamura; Yasuhiro Kanda; Hiroaki Matsumoto; Suguru Saito; Kazuyoshi Takeda; Toshihiko Kawamura; Toru Abo
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

8.  Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon.

Authors:  Nobuyuki Shimono; Lisa Morici; Nicola Casali; Sally Cantrell; Ben Sidders; Sabine Ehrt; Lee W Riley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

Review 9.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection.

Authors:  Nasiema Allie; Lena Alexopoulou; Valerie J F Quesniaux; Lizette Fick; Ksanthi Kranidioti; George Kollias; Bernhard Ryffel; Muazzam Jacobs
Journal:  Immunology       Date:  2008-06-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.